Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aztreonam measurement |
Component |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Monobactam adverse reaction |
Causative agent (attribute) |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam adverse reaction |
Causative agent (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Allergy to aztreonam (finding) |
Causative agent (attribute) |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 500 mg powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 1 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 2 g powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Product containing aztreonam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 20mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 40mg/mL injection solution 50mL plastic container |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 75mg powder for nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Allergy to aztreonam (finding) |
Causative agent (attribute) |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam lysine (substance) |
Is a |
False |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam 500 mg powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 500 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 2 g powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 2 g powder for solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam lysine (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
|
Aztreonam-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing only aztreonam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam only product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing aztreonam in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for infusion and/or injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam 1 g powder for solution for infusion and/or injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely aztreonam 2 gram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |
Aztreonam (as aztreonam lysine) 75 mg powder for inhalation solution vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Aztreonam (substance) |
Inferred relationship |
Some |
1 |